SCHEMBL17265620

SCHEMBL17265620

Cc1cc2oc(-c3ccccc3)cc(=O)c2c(O)c1C

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 8/20 0.80
▸ ABCG2 Q9UNQ0 4/20 0.72
▸ CREB1 P16220 5/20 0.68
▸ CYP3A4 P08684 5/20 0.68
▸ MAPT P10636 5/20 0.68
▸ SMN1; SMN2 Q16637 4/20 0.68
▸ TP53 P04637 3/20 0.68
▸ MEN1 O00255 3/20 0.68
▸ ALDH1A1 P00352 3/20 0.68
▸ CYP1A1 P04798 3/20 0.68
▸ CYP1A2 P05177 3/20 0.68
▸ KMT2A Q03164 3/20 0.68
▸ CYP1B1 Q16678 3/20 0.68
▸ FTO Q9C0B1 3/20 0.68
▸ CYP2C9 P11712 3/20 0.68
▸ CYP2C19 P33261 3/20 0.68
▸ PRSS1 P07477 2/20 0.68
▸ PRSS2 P07478 2/20 0.68
▸ PRSS3 P35030 2/20 0.68
▸ PTPRS Q13332 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13287220 0.90 ABCB1 (0.74) ABCB1ABCG2CREB1CYP3A4MAPT
SCHEMBL6245328 0.89 ABCB1 (1.00) ABCB1ABCG2CREB1CYP3A4MAPT
SCHEMBL22068804 0.84 ABCB1 (1.00) ABCB1ABCG2CREB1CYP3A4MAPT
SCHEMBL12978376 0.84 CREB1 (0.79) ABCB1ABCG2CREB1CYP3A4MAPT
SCHEMBL31675833 0.81 ABCB1 (0.74) ABCB1ABCG2CREB1CYP3A4MAPT
SCHEMBL1144261 0.81 ABCB1 (0.74) ABCB1ABCG2CREB1CYP3A4MAPT
Baicalein SCHEMBL28365951 0.81 ABCB1 (0.94) ABCB1ABCG2CREB1CYP3A4MAPT
Baicalein SCHEMBL5695785 0.81 ABCB1 (1.00) ABCB1ABCG2CREB1CYP3A4MAPT
Baicalein SCHEMBL29385549 0.81 ABCB1 (1.00) ABCB1ABCG2CREB1CYP3A4MAPT
Baicalein SCHEMBL139617 0.81 ABCB1 (1.00) ABCB1ABCG2CREB1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329515-A1 COMPOSITION AND METHOD FOR TREATING OR PREVENTING INFLUENZA VIRUS INFECTION NATIONAL DEFENSE MEDICAL CENTER (TW) 2015-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329515-A1 COMPOSITION AND METHOD FOR TREATING OR PREVENTING INFLUENZA VIRUS INFECTION HAVCR2, IRF3, IDO1 ABCB1 949/4885ABCG2 1177/4885CREB1 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback